Trial Site Detail

 

Drug:
Masitinib, (AB1010)
Trial:
A phase II study to compare efficacy and safety of masitinib at 12 mg/kg/day to sunitinib at 50 mg/day in treatment of patients with gastro-intestinal stromal tumor resistant to imatinib
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Unknown

 

Institut Gustave Roussy

     
Villejuif , Val de Narne 94805
France

 

Principal Investigator:
Axel Le Cesne
Contact:
+33-1-42-11-43-05 axel.lecesne@igr.fr
Activation Status of this Site:
Closed
Notes about this Site:
Institut Gustave Roussy Website:
http://www.gustaveroussy.fr/

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.